Articles related to CANCER SCREENING

Experts discussing rising breast cancer diagnoses cite both incidence increases and improved detection, alongside persistent concerns about diagnostic delays. The commentary does not establish that more patient-centered care explains the increase.

Early detection remains one of the strongest tools against prostate cancer, with localized disease associated with nearly 100% 5-year survival. An oncology nursing review highlights screening, risk stratification, precision medicine, and the expanding role of nurses in education, care coordination, and survivorship support.

Breast cancer remains the most prevalent cancer among U.S. women, with diagnoses and mortality projected to rise over the next two decades. Nurses play a central role in early recognition, patient education, treatment support, and ongoing surveillance throughout the care continuum.

Prebiopsy prostate MRI use increased substantially across US hospitals between 2017 and 2026, reflecting broader uptake of guideline-supported imaging, although a substantial proportion of patients still undergo biopsy without MRI evaluation.

Prostate cancer screening continues to rely on individualized risk assessment, PSA monitoring, and shared decision-making, while advances in MRI imaging and biomarker testing may help refine biopsy decisions and reduce unnecessary invasive procedures.

The American Gastroenterological Association issued nine best practice statements on colorectal and esophageal surveillance in older adults. Recommendations emphasize individualized decisions, life expectancy, treatment candidacy, procedural risks, and patient preferences.